Literature DB >> 2845959

Receptor binding of guinea pig and pig vasoactive intestinal peptides by rat lung.

S Paul1, D J Volle, J Currie.   

Abstract

Guinea pig vasoactive intestinal peptide (gpVIP) differs from other mammalian VIPs in four of its 28 amino acid residues. In the present study, the gpVIP displaced 125I-labelled pig VIP (pVIP) binding by rat lung membranes with 7.7-fold lower potency than pVIP. Degradation of gpVIP by rat lung membranes, assessed by radioimmunoassay and h.p.l.c., was 1.9-fold greater than that of pVIP. This difference in degradation of the two peptides was not large enough to account for the lower receptor-binding potency of gpVIP. The amino acid residues that distinguish pVIP from gpVIP are likely to contribute to the interaction of VIP with receptors and peptide hydrolases in lung membranes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845959      PMCID: PMC1135123          DOI: 10.1042/bj2540613

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.

Authors:  S I Said; V Mutt
Journal:  Eur J Biochem       Date:  1972-07-13

3.  Purification of [125I]-vasoactive intestinal peptide by reverse-phase HPLC.

Authors:  S Paul; K Wood; S I Said
Journal:  Peptides       Date:  1984 Nov-Dec       Impact factor: 3.750

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Isolation and characterization of rat vasoactive intestinal peptide.

Authors:  R Dimaline; J R Reeve; J E Shively; D Hawke
Journal:  Peptides       Date:  1984 Mar-Apr       Impact factor: 3.750

6.  Degradation of vasoactive intestinal polypeptide by tissue homogenates.

Authors:  T N Keltz; E Straus; R S Yalow
Journal:  Biochem Biophys Res Commun       Date:  1980-01-29       Impact factor: 3.575

7.  Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.

Authors:  N Itoh; K Obata; N Yanaihara; H Okamoto
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

8.  Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences.

Authors:  A Couvineau; C Rouyer-Fessard; A Fournier; S St Pierre; R Pipkorn; M Laburthe
Journal:  Biochem Biophys Res Commun       Date:  1984-06-15       Impact factor: 3.575

9.  Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution.

Authors:  Y Hamasaki; M Mojarad; T Saga; H H Tai; S I Said
Journal:  Am Rev Respir Dis       Date:  1984-05

10.  Isolation and characterization of bovine vasoactive intestinal peptide (VIP).

Authors:  M Carlquist; V Mutt; H Jörnvall
Journal:  FEBS Lett       Date:  1979-12-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.